This week, Leeaf CEO Olga Chabr Grillova and Co-Founder Jan Choma attended the 39th Annual ESHRE Meeting in Copenhagen, Denmark, to network with industry experts and forge new strategic partnerships for upcoming research projects and product development.
The event brought together leading fertility and reproduction experts, researchers, clinics and physicians and showcased first-class scientific research and innovation in human reproduction and embryology.
“The Leeaf Physician Portal and Patient mobile app bridge the gap between science and technology - it's applied science at its finest. We are at the forefront of fertility research. At ESHRE, we met with existing partners and forged new research and business alliances that will further help us improve diagnostics and treatment selection for future IVF patients," affirms Olga.
“Through the scope and unique character of our prospective research study, Leeaf will contribute to the qualitative transformation of assisted reproductive treatment and will undoubtedly improve existing IVF treatment procedures," concludes Jan.
As Leeaf on-board first US clinics and expands their research efforts overseas, the Scientific Board expects preliminary results of their multi-centric study in the second half of 2023.
